1 code implementation • 11 Aug 2022 • Quentin Blampey, Nadège Bercovici, Charles-Antoine Dutertre, Isabelle Pic, Fabrice André, Joana Mourato Ribeiro, Paul-Henry Cournède
Cytometry enables precise single-cell phenotyping within heterogeneous populations.
1 code implementation • 12 Sep 2022 • Hakim Benkirane, Yoann Pradat, Stefan Michiels, Paul-Henry Cournède
Recent advances in high-throughput sequencing technologies have enabled the extraction of multiple features that depict patient samples at diverse and complementary molecular levels.
1 code implementation • 27 Jun 2023 • Leo Fillioux, Joseph Boyd, Maria Vakalopoulou, Paul-Henry Cournède, Stergios Christodoulidis
In such cases, a whole slide image is modelled as a collection of tissue patches to be aggregated and classified.
no code implementations • 14 Dec 2020 • Martin Charachon, Céline Hudelot, Paul-Henry Cournède, Camille Ruppli, Roberto Ardon
From a given classifier, we train two generators to produce from an input image the so called similar and adversarial images.
no code implementations • 21 Jun 2021 • Martin Charachon, Paul-Henry Cournède, Céline Hudelot, Roberto Ardon
We show that visual explanation can be produced as the difference between two generated images obtained via two specific conditional generative models.
no code implementations • 20 Dec 2021 • Gurvan Hermange, William Vainchenker, Isabelle Plo, Paul-Henry Cournède
Myeloproliferative Neoplasms (MPN) are blood cancers that appear after acquiring a driver mutation in a hematopoietic stem cell.
no code implementations • 28 Aug 2023 • Leo Fillioux, Emilie Gontran, Jérôme Cartry, Jacques RR Mathieu, Sabrina Bedja, Alice Boilève, Paul-Henry Cournède, Fanny Jaulin, Stergios Christodoulidis, Maria Vakalopoulou
In particular, PDOs are attracting interest in the field of Functional Precision Medicine (FPM), which is based upon an ex-vivo drug test in which living tumor cells (such as PDOs) from a specific patient are exposed to a panel of anti-cancer drugs.
no code implementations • 16 Oct 2023 • Mouad El Bouchattaoui, Myriam Tami, Benoit Lepetit, Paul-Henry Cournède
Under unconfoundedness, we target the Individual Treatment Effect (ITE) estimation with unobserved heterogeneity in the treatment response due to missing risk factors.